Bioavailability of tyrosine kinase inhibitors: an added component of assessment

Area of Science:

• Oncology
• Pharmacology
• Drug Metabolism

Background:

• Tyrosine kinase inhibitors (TKIs) are increasingly used to treat malignancies.
• TKIs are oral agents with bioavailability distinct from parenteral drugs.
• Patient assessment by oncology nurses must adapt to TKIs' unique properties.

Purpose of the Study:

• To review key factors influencing TKI absorption and metabolism.
• To inform oncology nurses about drug interactions affecting TKI efficacy.
• To highlight the importance of understanding drug bioavailability in cancer therapy.

Main Methods:

• Literature review of drug absorption and metabolism.
• Analysis of factors affecting oral drug bioavailability.
• Examination of specific interactions relevant to TKIs.

Main Results:

• Changes in stomach pH can alter TKI absorption.
• P-glycoprotein interactions impact TKI distribution and efficacy.
• Cytochrome P450 enzyme interactions affect TKI metabolism.

Conclusions:

• Oncology nurses need to consider stomach pH, P-glycoprotein, and cytochrome P450 for TKI therapy.
• Awareness of these factors optimizes TKI dosing and patient outcomes.
• Comprehensive patient assessment is vital for TKI treatment success.